Future Tbit™ blood test applications depend on emerging biomarker research that is leading to a new era in diagnostics. Other neurological conditions that may potentially be diagnosed through biomarkers include stroke and Alzheimer’s disease.
795,000 New Strokes Annually
5.4 million Americans currently suffer from Alzheimer's disease.
Not FDA approved and currently for research use only. Not for use in diagnostic procedures.
BioDirection is always searching for new opportunities. Contact us today with any questions or inquiries.